BIOCEPT, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2022-09-07: Study NCT05414123; Company role Lead sponsor; Phase Observational; Status Terminated.
- 2018-01-26: Study NCT02965755; Company role Collaborator; Phase Not applicable; Status Active not recruiting.
- 2017-02-06: Study NCT02948751; Company role Collaborator; Phase Not applicable; Status Completed.
- 1990-04: Study NCT00578240; Company role Collaborator; Phase Observational; Status Active not recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2022-09-07 | NCT05414123 A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide | Lead sponsor | Observational | Terminated | Leptomeningeal Metastasis; Leptomeningeal Disease; Leptomeningeal Neoplasms; Breast Cancer; Non-Small Cell Lung Cancer | 40 | 2023-10-13 |
| 2018-01-26 | NCT02965755 Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins | Collaborator Lead: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Not applicable | Active not recruiting | Metastatic Breast Cancer | 200 | 2027-06 |
| 2017-02-06 | NCT02948751 Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer | Collaborator Lead: Columbia University | Not applicable | Completed Results posted | Breast Cancer; Leptomeningeal Metastasis | 14 | 2019-12-18 |
| 1990-04 | NCT00578240 Molecular Studies and Clinical Correlations in Human Prostatic Disease | Collaborator Lead: Memorial Sloan Kettering Cancer Center | Observational | Active not recruiting | Prostate Cancer | 5,290 | 2026-12 |